Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 27, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Sentinel Lymph NodeBreast CancerTattoo; PigmentationAxilla; Breast
Interventions
PROCEDURE

Tattooing of biopsied node

Tattooing (marking) of biopsied node with carbon dye (SPOT dye) at the time of fine needle aspiration or core biopsy or separate visit under ultrasound guidance. The dye will be injected in the cortex of the node and the perinodal tissue under ultrasound guidance. Patients will undergo standard (routine) armpit surgery and may receive neoadjuvant chemotherapy as planned by the clinical team. This could be removal of a few lymph glands (sentinel node biopsy) or removal of all the lymph glands (axillary lymph node dissection) in the armpit. The surgeon will try to identify and remove the tattooed lymph gland at the time of planned armpit surgery.

Trial Locations (1)

DE22 3NE

Royal Derby Hospital, Derby

All Listed Sponsors
lead

University Hospitals of Derby and Burton NHS Foundation Trust

OTHER

NCT03640819 - Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer | Biotech Hunter | Biotech Hunter